Clarity Pharmaceuticals Email Format

Biotechnology ResearchNew South Wales, Australia51-200 Employees

Clarity Pharmaceuticals is a clinical-stage biotechnology company based in Sydney, New South Wales, focused on radiopharmaceuticals for cancer. It develops a copper-based Targeted Copper Theranostics platform that pairs copper-64 for imaging with copper-67 for therapy, aiming to deliver high-precision diagnosis and treatment while addressing supply and logistics advantages over existing approaches.

Its product pipeline includes large indications such as prostate and breast cancer as well as smaller indications like neuroendocrine tumours and neuroblastoma. The company pursues development across both adult and pediatric cancer populations. In March 2026, Clarity announced a manufacturing supply agreement with Theragenics to support copper-64–based imaging agents.

Get verified Clarity Pharmaceuticals emails free

Company overview Employee directory